Lawrence Lee
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Epidemiology 20
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- HIV/AIDS drug development and treatment 13
- Co-authors
- Melvin Khee‐Shing Leow (6 shared papers)Arul Earnest (4 shared papers)Charles Flexner (11 shared papers)Gregory Kaw (5 shared papers)Nicholas I. Paton (4 shared papers)Eu‐Leong Yong (8 shared papers)Peter Palukaitis (3 shared papers)Stewart M. Gray (3 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)CHEST Journal (3 papers)Surgical Endoscopy (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesSingaporeCanada
In The Last Decade
Lawrence Lee
73 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 138
- Infectious Diseases 694
- Pharmacology 247
- Neurology 340
- Virology 96
- Critical Care and Intensive Care Medicine 99
Countries citing papers authored by Lawrence Lee
This map shows the geographic impact of Lawrence Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Lee more than expected).
Fields of papers citing papers by Lawrence Lee
This network shows the impact of papers produced by Lawrence Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Lee. The network helps show where Lawrence Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 218 | |
| 2 | 2005 | 210 | |
| 3 | 2011 | 141 | |
| 4 | 2004 | 104 | |
| 5 | 2016 | 89 | |
| 6 | 2006 | 86 | |
| 7 | 2005 | 85 | |
| 8 | 2018 | 69 | |
| 9 | 2004 | 69 | |
| 10 | 2019 | 68 | |
| 11 | 2012 | 66 | |
| 12 | 2006 | 66 | |
| 13 | 2009 | 64 | |
| 14 | 2017 | 61 | |
| 15 | 2014 | 60 | |
| 16 | 2009 | 53 | |
| 17 | 2002 | 52 | |
| 18 | 2012 | 49 | |
| 19 | 2014 | 46 | |
| 20 | 2007 | 38 |
About Lawrence Lee
Lawrence Lee is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Cognitive Neuroscience and Pharmacology, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), Sleep and Wakefulness Research (11 papers), Sleep and related disorders (8 papers), HIV Research and Treatment (6 papers), Natural product bioactivities and synthesis (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Long-Term Effects of COVID-19 (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). The work is most often cited by research in Infectious Diseases (694 citations), Pharmacology (247 citations), Neurology (340 citations), Virology (96 citations) and Critical Care and Intensive Care Medicine (99 citations). Lawrence Lee has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Melvin Khee‐Shing Leow, Arul Earnest, Charles Flexner, Gregory Kaw, Nicholas I. Paton, Eu‐Leong Yong, Peter Palukaitis, Stewart M. Gray, Ping Shen and Kim‐Hor Hee. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Antimicrobial Agents and Chemotherapy, CHEST Journal, Surgical Endoscopy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.